Antianxiety Agents

  • Samuel Gershon
Part of the Advances in Behavioral Biology book series (ABBI, volume 6)


It should be stressed at the outset that this presentation will mainly point out the deficiencies in our knowledge rather than present any substantial body of scientifically significant data. There is a dearth of information on specific therapeutic efficacy of anti-anxiety agents in the geriatric population, In aspects of differential side effects, on potential differences in metabolic handling, and on drug interaction problems that may arise when anti-anxiety agents are given concurrently with drugs employed for medical management. In determining the therapeutic efficacy of these drugs we must consider such problems as a potentially high placebo response rate and the choice of psychological rating scales which are relevant and sensitive to an elderly population. Salzman and Shader have outlined the difficulties encountered by investigators in this area. We will discuss these problems in terms of each of the following categories: a) population, b) diagnosis, and c) chemotherapeutic agents.


Nursing Home Anxiety Reaction Geriatric Patient Geriatric Population Organic Brain Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aldrich, C.K., and Mendkoff, E. Relocation of the aged and disabled: A mortality study. J. Am. Ger. Soc., 11, 185–194, 1963.Google Scholar
  2. Bender, A.D.: Pharmacologic aspects of aging: A survey of the effect of increasing age on drug activity in adults. J. Amer. Ger. Soc. 12; 114–134, 1964.Google Scholar
  3. Blenkner, M. Environmental change and the aging individual. Gerontologist: 7, 101–105, 1967.PubMedCrossRefGoogle Scholar
  4. Chesrow; E.J., Kaplitz, S.E., Breme, J.T., Musci, J. and Sabatini, R. Use of a new benzodiazepine derivative (VALIUM) in chronically ill and disturbed elderly patients. J. Am. Ger. Soc. 10, 667–670, 1962.Google Scholar
  5. Deutsch, M., Saxena, B.M., Lehmann, H.E. and Ban, T.A. Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients. Curr. Ther. Res. 12, 805–509, 1970.PubMedGoogle Scholar
  6. Feigenbaum, E.M. Assessment of behavioral changes and emotional disturbances in a custodial geriatric facility. Presented as a Scientific Exhibit, 124 Annual Meeting Amer. Psychiat. Assoc. Wash. D.C. May 3–7, 1971.Google Scholar
  7. Gibson, I: I.J.M.: Barbiturate delirium. Practitioner 197: 345–7, 1966.PubMedGoogle Scholar
  8. Jasnau, K.E. Individual versus mass transfer of neuropsychotic geriatric patients from mental hospitals to nursing homes, with special reference to the death rate. J. Am. Geriat. Soc. 15, 280–284, 1967.PubMedGoogle Scholar
  9. Jones, T.H.: Chloriazepoxide and the geriatric patient. J. Am. Ger. Soc. 10, 259–263, 1962.Google Scholar
  10. Kral, V.A. The use of thioridazine in aged people. Canad. Med. Ass. J. 84, 152, 1961.PubMedGoogle Scholar
  11. Lawton, M.P. and Jaffee, S. Mrtality, morbidity, and voluntary change of residence of older people. Paper presented at Annual Meeting of American Psychological Association, Washington, Sept. 5, 1967.Google Scholar
  12. Lieberman, M.A. Relationship of mortality rates to entrance to a home for the aged. Geriatrics, 16, 575–579, 1961.Google Scholar
  13. Miller, D., and Lieberman, M.A. The relationship of affect state and adaptive capacity to reactions to stress. J. of Geront. 20, 492–297, 1965.Google Scholar
  14. Roth, M. The natural history of mental disorder in old age. J. Ment. Sei. 101, 281, 1955.Google Scholar
  15. Salzman, C., Gochansky, G.E., and Shader, R.I., Rating scales for geriatric psychopharmacology.Google Scholar
  16. Salzman, C., Shader, R.I., and Perlman, M.: Psychopharmacology and the elderly, In Shader, R.I. and Di Mascio, A. (Eds.). Psychotropic Drug Side Effects. Williams and Wilkins, Baltimore, 1970, 261–279.Google Scholar
  17. Shader, R.I. and DiMascio, A. Psychotropic Drug Side Effects. Williams and Wilkins, 1970.Google Scholar
  18. Shahinian, S.F., Goldforb, A.I., and Turner, M. Death rate in relocated residents of nursing homes. Paper presented at 19th Annual Meeting of Gerontological Society. N.Y.: Nov. 4, 1966.Google Scholar

Copyright information

© Plenum Press, New York 1973

Authors and Affiliations

  • Samuel Gershon

There are no affiliations available

Personalised recommendations